Whooping cough vaccine safety checked in 2,700 pregnant women and their babies
NCT ID NCT06888076
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study reviews medical records of about 2,700 pregnant women in Thailand who received the Pertagen® whooping cough vaccine and later gave birth between 2021 and 2024. Researchers will track whether the women had full-term or premature deliveries, any delivery complications, and whether their babies were healthy at birth. The goal is to confirm the vaccine's safety for both mother and child.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERTUSSIS VACCINES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Medicine Siriraj Hospital Mahidol University
Bangkok, Bangkok, 10700, Thailand
Conditions
Explore the condition pages connected to this study.